Head and Neck Squamous Cell Carcinoma (HNSCC)Symptoms, Doctors, Treatments, Advances & More
Learn About Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
UPMC Hillman Cancer Center
Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Zandberg is board certified in American Board Of Internal Medicine. Dr. Zandberg is currently accepting new patients.
Jefferson Otolaryngology (ENT) - Honickman Center
Adam Luginbuhl is an Otolaryngologist practicing medicine in Philadelphia, Pennsylvania. Dr. Luginbuhl is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Laryngectomy, and Gastrostomy. Dr. Luginbuhl is board certified in Otolaryngology - Head & Neck Surgery and Otolaryngology. Dr. Luginbuhl is currently accepting new patients.
Jefferson Otolaryngology (ENT) - Honickman Center
David Cognetti is an Otolaryngologist practicing medicine in Philadelphia, Pennsylvania. Dr. Cognetti is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Duct Stones, Sialadenitis, Laryngectomy, and Gastrostomy. Dr. Cognetti is board certified in Otolaryngology - Head & Neck Surgery and Otolaryngology. Dr. Cognetti is currently accepting new patients.
Summary: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer. Oropharynx SCC (OPSCC) is a common sub-type of HNSCC. Each year, 16,000 new cases of OPSCC are diagnosed in the USA. Most cases of OPSCC (\>90%) are caused by the human papillomavirus (HPV) and are often cured with current therapy. However, patients treated with surgery followed by postoperative adjuvant chemotherapy an...
Summary: To find the recommended dose of an investigational therapy called chimeric antigen receptor (CAR).TROP2/interleukin (IL)15-transduced TGFBR2 KO cord blood (CB)-derived natural killer (NK) cells (TROP2 CAR/IL-15 TGFBR2 KO NK cells) that can be given with and without preconditioning radiation therapy in patients with advanced head and neck squamous cell carcinoma.